Rigel Pharmaceuticals Inc (RIGL) — Net Asset Quality Index
Rigel Pharmaceuticals Inc (RIGL) has a Net Asset Quality Index of 79.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $504.61 Million minus total liabilities of $104.71 Million yields net assets of $399.90 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RIGL asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rigel Pharmaceuticals Inc Net Asset Quality Index Over Time (1999–2025)
This chart shows how Rigel Pharmaceuticals Inc's Net Asset Quality Index has evolved across 27 annual periods from 1999 to 2025. As of March 2026, the index stands at 79.2%, representing net assets of $399.90 Million against total assets of $504.61 Million USD. See Rigel Pharmaceuticals Inc (RIGL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Rigel Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Net Asset Quality Index for Rigel Pharmaceuticals Inc from 1999 to 2025, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Rigel Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.2% | $391.48 Million | $513.59 Million | $122.11 Million | ▲ +74.2 pp |
| 2024 | 2.0% | $3.29 Million | $163.98 Million | $160.69 Million | ▲ +26.4 pp |
| 2023 | -24.4% | $-28.64 Million | $117.22 Million | $145.87 Million | ▼ -14.3 pp |
| 2022 | -10.1% | $-13.62 Million | $134.28 Million | $147.90 Million | ▼ -28.3 pp |
| 2021 | 18.2% | $30.37 Million | $167.33 Million | $136.95 Million | ▼ -12.7 pp |
| 2020 | 30.8% | $34.03 Million | $110.38 Million | $76.35 Million | ▼ -5.6 pp |
| 2019 | 36.5% | $53.81 Million | $147.57 Million | $93.75 Million | ▼ -42.5 pp |
| 2018 | 79.0% | $109.88 Million | $139.11 Million | $29.23 Million | ▼ -5.5 pp |
| 2017 | 84.5% | $100.65 Million | $119.11 Million | $18.46 Million | ▲ +14.1 pp |
| 2016 | 70.4% | $55.03 Million | $78.13 Million | $23.11 Million | ▲ +1.1 pp |
| 2015 | 69.4% | $91.38 Million | $131.75 Million | $40.37 Million | ▼ -13.8 pp |
| 2014 | 83.2% | $128.25 Million | $154.13 Million | $25.89 Million | ▼ -8.9 pp |
| 2013 | 92.1% | $208.25 Million | $226.06 Million | $17.81 Million | ▼ -1.1 pp |
| 2012 | 93.2% | $289.10 Million | $310.04 Million | $20.95 Million | ▲ +1.4 pp |
| 2011 | 91.8% | $236.15 Million | $257.11 Million | $20.96 Million | ▲ +2.9 pp |
| 2010 | 89.0% | $166.13 Million | $186.69 Million | $20.56 Million | ▲ +10.9 pp |
| 2009 | 78.1% | $109.87 Million | $140.74 Million | $30.88 Million | ▲ +5.7 pp |
| 2008 | 72.4% | $104.17 Million | $143.86 Million | $39.69 Million | ▲ +1.4 pp |
| 2007 | 71.0% | $82.18 Million | $115.79 Million | $33.61 Million | ▼ -6.1 pp |
| 2006 | 77.0% | $87.23 Million | $113.24 Million | $26.01 Million | ▲ +3.5 pp |
| 2005 | 73.5% | $108.59 Million | $147.67 Million | $39.08 Million | ▲ +7.2 pp |
| 2004 | 66.4% | $52.30 Million | $78.82 Million | $26.52 Million | ▼ -5.6 pp |
| 2003 | 72.0% | $39.97 Million | $55.52 Million | $15.55 Million | ▲ +14.6 pp |
| 2002 | 57.4% | $25.44 Million | $44.34 Million | $18.90 Million | ▼ -4.9 pp |
| 2001 | 62.3% | $28.94 Million | $46.45 Million | $17.51 Million | ▼ -14.0 pp |
| 2000 | 76.3% | $49.01 Million | $64.26 Million | $15.25 Million | ▲ +71.9 pp |
| 1999 | 4.4% | $756.00K | $17.17 Million | $16.41 Million | — |